Widman M[au] - Search Results

Year	Number of Results
1969	1
1971	1
1973	3
1974	4
1975	2
1976	2
1977	4
1978	4
1979	2
1980	1
1982	3
1983	1
1984	1
1985	1
1986	1
1989	2
1990	1
1992	1
1993	3
1994	1
1996	4
1997	3
1998	2
1999	2
2000	1
2002	1
2003	1
2021	0

1

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Agurell S, et al. Among authors: widman m. Pharmacol Rev. 1986 Mar;38(1):21-43. Pharmacol Rev. 1986. PMID: 3012605 Review. No abstract available.

2

Clinical pharmacokinetics of remoxipride.

von Bahr C, Movin G, Yisak WA, Jostell KG, Widman M. von Bahr C, et al. Among authors: widman m. Acta Psychiatr Scand Suppl. 1990;358:41-4. doi: 10.1111/j.1600-0447.1990.tb05284.x. Acta Psychiatr Scand Suppl. 1990. PMID: 1978486 Review.

3

In vitro characterization of polyorthoester microparticles containing bupivacaine.

Deng JS, Li L, Tian Y, Ginsburg E, Widman M, Myers A. Deng JS, et al. Among authors: widman m. Pharm Dev Technol. 2003;8(1):31-8. doi: 10.1081/pdt-120017521. Pharm Dev Technol. 2003. PMID: 12665195

4

Two cannabidiol metabolites formed by rat liver.

Nilsson I, Agurell S, Nilsson JL, Widman M, Leander K. Nilsson I, et al. Among authors: widman m. J Pharm Pharmacol. 1973 Jun;25(6):486-7. doi: 10.1111/j.2042-7158.1973.tb09138.x. J Pharm Pharmacol. 1973. PMID: 4146589 No abstract available.

5

Metabolism and excretion of ropivacaine in humans.

Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M. Halldin MM, et al. Among authors: widman m. Drug Metab Dispos. 1996 Sep;24(9):962-8. Drug Metab Dispos. 1996. PMID: 8886605 Clinical Trial.

6

Plasma protein binding of 7-hydroxy- 1-tetrahydrocannabinol: an active 1-tetrahydrocannabinol metabolite.

Widman M, Nilsson IM, Agurell S, Borg H, Granstrand B. Widman M, et al. J Pharm Pharmacol. 1973 Jun;25(6):453-7. doi: 10.1111/j.2042-7158.1973.tb09132.x. J Pharm Pharmacol. 1973. PMID: 4146583 No abstract available.

7

Acidic in vivo metabolites of cannabinol isolated from rat faeces.

Yisak AW, Widman M, Agurell S. Yisak AW, et al. Among authors: widman m. J Pharm Pharmacol. 1978 Sep;30(9):554-7. doi: 10.1111/j.2042-7158.1978.tb13322.x. J Pharm Pharmacol. 1978. PMID: 29093

8

Dihydroxylated metabolites of cannabinol formed by rat liver in vitro.

Fonseka K, Widman M. Fonseka K, et al. Among authors: widman m. J Pharm Pharmacol. 1977 Jan;29(1):12-4. doi: 10.1111/j.2042-7158.1977.tb11229.x. J Pharm Pharmacol. 1977. PMID: 13175

9

The development of an injection-molding process for a polyanhydride implant containing gentamicin sulfate.

Deng JS, Meisters M, Li L, Setesak J, Claycomb L, Tian Y, Stephens D, Widman M. Deng JS, et al. Among authors: widman m. PDA J Pharm Sci Technol. 2002 Mar-Apr;56(2):65-77. PDA J Pharm Sci Technol. 2002. PMID: 11977406

10

Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.

Widman M, Nordqvist M, Dollery CT, Briant RH. Widman M, et al. J Pharm Pharmacol. 1975 Nov;27(11):842-8. doi: 10.1111/j.2042-7158.1975.tb10227.x. J Pharm Pharmacol. 1975. PMID: 1493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results